Effectiveness of Topical Antibiotic Prophylaxis in Inguinal Hernia Repair
- Conditions
- Inguinal Hernia
- Interventions
- Registration Number
- NCT01273818
- Lead Sponsor
- Diskapi Teaching and Research Hospital
- Brief Summary
Aim of this study is to measure the effectiveness of topical gentamicin to prevent post-operative infection in inguinal tension-free hernia repair operation.Secondary aim is, if it is effective as a prophylactic agent, to compare it's effect with intra venous single dose cefazolin sodium prophylaxis.
- Detailed Description
This study is a single blind prospective randomized trial. To measure and compare the effectiveness intra-operative topical gentamicin application in tension-free inguinal hernia repair in contrast to intravenous peri-operative prophylactic cefazolin sodium and combination of gentamicin and cephazolin this study is designed.
The patients are grouped randomly in to two groups:
* Group1;intravenous cefazolin sodium
* Group2;topical gentamicin
* Group3:topical gentamicin and intravenous cefazolin sodium
As a control group we decided to use the data of control groups ( without any prophylactic agent usage ) of previous studies done in our clinic and medical data base reviews.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 276
- Clinical diagnosis of inguinal hernia
- Femoral hernia
- Emergency cases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cefazolin Cefazolin Application of 1000 mg cefazolin intra venously 1 hour before surgery gentamicin and cefazolin Gentamicin and cefazolin 1000 mg cefazolin application 1 hour before surgery and topical 80 mg gentamicin intraoperatively gentamicin Gentamicin 80 mg gentamicin topical application intraoperatively
- Primary Outcome Measures
Name Time Method Rate of Post-operative Infection within the first 30 days after surgery Number of Infections in Each Study Arm within the 30 days after surgery Patients were examined on postoperative 30 days for the presence of surgical site infection.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Diskapi Yildirim Beyazit Teaching and research Hospital
🇹🇷Ankara, Turkey